---
figid: PMC7497849__nihms-1623924-f0003
figtitle: CCL5-VEGF-A signaling pathway in BEV treatment
organisms:
- Homo sapiens
- Mus musculus
- Human immunodeficiency virus
pmcid: PMC7497849
filename: nihms-1623924-f0003.jpg
figlink: pmc/articles/PMC7497849/figure/F3/
number: F3
caption: CCL5-VEGF-A signaling pathway in BEV treatment. RANTES, Regulated upon Activation
  Normal T cell Expressed and Secreted; MIP-1-alpha or -beta, macrophage inflammatory
  protein 1-alpha or beta; HRE, Hypoxia-response element; EPC, endothelial progenitor
  cell.
papertitle: Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict
  efficacy of bevacizumab in metastatic colorectal cancer patients.
reftext: Mitsukuni Suenaga, et al. Int J Cancer. ;144(10):2567-2577.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.958735
figid_alias: PMC7497849__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7497849__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7497849__nihms-1623924-f0003.html
  '@type': Dataset
  description: CCL5-VEGF-A signaling pathway in BEV treatment. RANTES, Regulated upon
    Activation Normal T cell Expressed and Secreted; MIP-1-alpha or -beta, macrophage
    inflammatory protein 1-alpha or beta; HRE, Hypoxia-response element; EPC, endothelial
    progenitor cell.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Klf13
  - Ccl5
  - Tnpo1
  - Zfp667
  - Ccr5
  - Vegfa
  - Kdr
  - Ccl4
  - Src
  - Hif1a
  - KLF13
  - CCL5
  - TNPO1
  - RPTOR
  - MAPKAP1
  - ADGRL3
  - CCR5
  - VEGFA
  - KDR
  - CCL4
  - CCL4L1
  - SRC
  - HIF1A
  - Regorafenib
  - tumor
  - MIP-1B
---
